That is the entire relationship
Pushback from Novo Nordisk In a statement sent to Business Insider, the semaglutide maker Novo Nordisk said: "Patient safety is a top priority for Novo Nordisk, and we take all reports about adverse events from the use of our medicines very seriously." But the drugmaker raised concerns about the ways this study was conducted, saying there were too few cases in the trial to draw meaningful conclusions and that this type of backward-looking study could never answer questions about a causal link between semaglutide and NAION
These include continued caloric awareness, regular resistance training, adequate protein intake, stress management, and potentially transitioning to a GLP-1 maintenance dose rather than stopping completely
This was the BEST thing I found to truly help me on my journey to a better lift thank you Citizen meds
One or two HIIT sessions weekly maximum, separated from resistance training by at least several hours, provides variety and conditioning benefits
